SW
TMDX icon

SlateStone Wealth’s Transmedics TMDX Stock Holding History

SlateStone Wealth’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,271
Closed -$204K – 299
2024
Q4 		$204K Sell
3,271
-5,187
-61% -$483K 0.02% 273
2024
Q3 		$1.33M Buy
8,458
+2,777
+49% +$428K 0.12% 128
2024
Q2 		$856K Buy
+5,681
New +$681K 0.09% 161

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SlateStone Wealth's TMDX Position: Q1 2025 in Review

SlateStone Wealth sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 3,271 shares — an estimated $204K sold.

SlateStone Wealth first reported a position in TMDX in Q2 2024 and held it in 3 quarters. The position peaked at $1.33M in Q3 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • SlateStone Wealth reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • SlateStone Wealth sold 3,271 Transmedics shares in Q1 2025, an estimated $204K.
  • SlateStone Wealth first reported a position in Transmedics in Q2 2024 and held it in 3 quarters.
  • SlateStone Wealth's Transmedics position peaked at $1.33M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on SlateStone Wealth's 13F filing for Q1 2025, filed 8 May 2025.